Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
Ypsomed hands off insulin pen needle business
Ypsomed sold its operations to the global medtech manufacturer and distributor MTD Group, which maintains production facilities in Italy and Poland.
Conor Hale
Mar 28, 2024 11:59am
Avalo snaps up AlmataBio for ex-Lilly inflammatory drug
Mar 28, 2024 8:26am
Gamida accepts sale to investment firm to survive
Mar 27, 2024 9:53am
AbbVie grabs a wrench to add immunology-focused Landos Biopharma
Mar 25, 2024 9:20am
Novo Nordisk inks $1B buyout to pump up heart failure plans
Mar 25, 2024 7:20am
Mendaera picks up Avail Medsystems' COVID-era virtual OR assets
Mar 19, 2024 11:26am